BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23474764)

  • 1. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.
    Allen-Petersen BL; Carter CJ; Ohm AM; Reyland ME
    Oncogene; 2014 Mar; 33(10):1306-15. PubMed ID: 23474764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.
    Ma Z; Parris AB; Howard EW; Shi Y; Yang S; Jiang Y; Kong L; Yang X
    Carcinogenesis; 2018 Oct; 39(10):1264-1273. PubMed ID: 30107476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
    Mancini ML; Lien EC; Toker A
    Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
    Boulay PL; Mitchell L; Turpin J; Huot-Marchand JÉ; Lavoie C; Sanguin-Gendreau V; Jones L; Mitra S; Livingstone JM; Campbell S; Hallett M; Mills GB; Park M; Chodosh L; Strathdee D; Norman JC; Muller WJ
    Cancer Res; 2016 May; 76(9):2662-74. PubMed ID: 26933086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity.
    Kuang X; Salinger A; Benavides F; Muller WJ; Dent SYR; Koutelou E
    PLoS One; 2024; 19(1):e0290837. PubMed ID: 38236941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
    Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB2 is required for ductal morphogenesis of the mammary gland.
    Jackson-Fisher AJ; Bellinger G; Ramabhadran R; Morris JK; Lee KF; Stern DF
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17138-43. PubMed ID: 15569931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
    Chen H; Pimienta G; Gu Y; Sun X; Hu J; Kim MS; Chaerkady R; Gucek M; Cole RN; Sukumar S; Pandey A
    Proteomics; 2010 Nov; 10(21):3800-10. PubMed ID: 20960451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor loss impairs mammary tumorigenesis in mice.
    Podmore L; Poloz Y; Iorio C; Mouaaz S; Nixon K; Smirnov P; McDonnell B; Lam S; Zhang B; Tharmapalan P; Sarkar S; Vyas F; Ennis M; Dowling R; Stambolic V
    Cell Rep; 2023 Nov; 42(11):113251. PubMed ID: 37913774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer.
    Chaib M; Holt JR; Fisher EL; Sipe LM; Bohm MS; Joseph SC; Simmons BW; Eugin Simon S; Yarbro JR; Tanveer U; Halle JL; Carson JA; Hollingsworth TJ; Wei Q; Rathmell JC; Thomas PG; Hayes DN; Makowski L
    Sci Adv; 2023 Dec; 9(51):eadd3231. PubMed ID: 38134280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for cancer pathogenesis and therapy.
    Speidel JT; Affandi T; Jones DNM; Ferrara SE; Reyland ME
    Adv Biol Regul; 2020 Dec; 78():100757. PubMed ID: 33045516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment.
    Yuan H; Wang X; Lu J; Zhang Q; Brandina I; Alexandrov I; Glazer RI
    Oncotarget; 2018 Jan; 9(8):8042-8053. PubMed ID: 29487713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the Shared and Context-Dependent Pathways Mediated by the p140Cap Adaptor Protein in Cancer and in Neurons.
    Chapelle J; Sorokina O; McLean C; Salemme V; Alfieri A; Angelini C; Morellato A; Adrait A; Menna E; Matteoli M; Couté Y; Ala U; Turco E; Defilippi P; Armstrong JD
    Front Cell Dev Biol; 2019; 7():222. PubMed ID: 31681758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein kinase C delta leads to cellular senescence to induce anti-tumor effects in colorectal cancer.
    Shimoyama Y; Yamada K; Yoshida S; Kawamura A; Hannya Y; Imaizumi Y; Kumamoto T; Takeda Y; Shimoda M; Eto K; Yoshida K
    Cancer Sci; 2023 Jun; 114(6):2471-2484. PubMed ID: 36851883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status.
    Bader JM; Deigendesch N; Misch M; Mann M; Koch A; Meissner F
    Cell Rep Med; 2023 Jan; 4(1):100877. PubMed ID: 36584682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancer.
    Zuo YH; Gao WN; Xie YJ; Yang SY; Zhou JT; Liang HH; Fan XX
    BMC Med; 2022 Dec; 20(1):470. PubMed ID: 36482371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model.
    Loots DT; Adeniji AA; Van Reenen M; Ozturk M; Brombacher F; Parihar SP
    Metabolomics; 2022 Nov; 18(11):92. PubMed ID: 36371785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer.
    Kawano T; Inokuchi J; Eto M; Murata M; Kang JH
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.
    Havugimana PC; Goel RK; Phanse S; Youssef A; Padhorny D; Kotelnikov S; Kozakov D; Emili A
    Nat Commun; 2022 Jul; 13(1):4043. PubMed ID: 35831314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.
    Saleiro D; Wen JQ; Kosciuczuk EM; Eckerdt F; Beauchamp EM; Oku CV; Blyth GT; Fischietti M; Ilut L; Colamonici M; Palivos W; Atsaves PA; Tan D; Kocherginsky M; Weinberg RS; Fish EN; Crispino JD; Hoffman R; Platanias LC
    Nat Commun; 2022 Apr; 13(1):1750. PubMed ID: 35365653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.